---
document_datetime: 2025-11-23 08:01:58
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/lifmior.html
document_name: lifmior.html
version: success
processing_time: 0.1055128
conversion_datetime: 2025-12-28 09:32:47.710951
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Lifmior

[RSS](/en/individual-human-medicine.xml/65907)

##### Lapsed

This medicine's authorisation has lapsed

etanercept

Medicine

Human

Lapsed

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Lifmior](#news-on)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 16 February 2020, the marketing authorisation of Lifmior (etanercept) ceased to be valid in the European Union (EU). The cessation of validity is due to the fact that the marketing authorisation holder, Pfizer Europe MA EEIG, had not marketed Lifmior in the EU since its initial marketing authorisation. In accordance with provisions of the sunset clause1, the marketing authorisation of the medicinal product lapsed as the product had not been marketed in any of the EU Member States within three years of its initial authorisation. Pfizer Europe MA EEIG confirmed that the product had not been marketed for commercial reasons.

Lifmior was granted marketing authorisation in the EU on 13 February 2017 for treatment of rheumatoid arthritis in adults, certain forms of juvenile idiopathic arthritis, plaque psoriasis in adults and children, psoriatic arthritis in adults, ankylosing spondylitis in adults and axial spondyloarthritis in adults. The marketing authorisation was initially valid for a 5-year period.

Lifmior is an identical product to Enbrel, the reference medicinal product. There are biosimilar medicinal products of Enbrel authorised and marketed in the EU.

The European Public Assessment Report (EPAR) for Lifmior is updated to indicate that the marketing authorisation is no longer valid.

Lifmior : EPAR - Summary for the public

English (EN) (667.44 KB - PDF)

**First published:** 13/03/2017

**Last updated:** 20/02/2020

[View](/en/documents/overview/lifmior-epar-summary-public_en.pdf)

[Other languages (22)](#file-language-dropdown-59)

български (BG) (764.72 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/bg/documents/overview/lifmior-epar-summary-public_bg.pdf)

español (ES) (666.22 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/es/documents/overview/lifmior-epar-summary-public_es.pdf)

čeština (CS) (743.13 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/cs/documents/overview/lifmior-epar-summary-public_cs.pdf)

dansk (DA) (664.7 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/da/documents/overview/lifmior-epar-summary-public_da.pdf)

Deutsch (DE) (669.02 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/de/documents/overview/lifmior-epar-summary-public_de.pdf)

eesti keel (ET) (663.42 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/et/documents/overview/lifmior-epar-summary-public_et.pdf)

ελληνικά (EL) (766 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/el/documents/overview/lifmior-epar-summary-public_el.pdf)

français (FR) (667.79 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/fr/documents/overview/lifmior-epar-summary-public_fr.pdf)

hrvatski (HR) (687.98 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/hr/documents/overview/lifmior-epar-summary-public_hr.pdf)

italiano (IT) (663.91 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/it/documents/overview/lifmior-epar-summary-public_it.pdf)

latviešu valoda (LV) (741.47 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/lv/documents/overview/lifmior-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (692.66 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/lt/documents/overview/lifmior-epar-summary-public_lt.pdf)

magyar (HU) (736.23 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/hu/documents/overview/lifmior-epar-summary-public_hu.pdf)

Malti (MT) (744 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/mt/documents/overview/lifmior-epar-summary-public_mt.pdf)

Nederlands (NL) (666.25 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/nl/documents/overview/lifmior-epar-summary-public_nl.pdf)

polski (PL) (741.21 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/pl/documents/overview/lifmior-epar-summary-public_pl.pdf)

português (PT) (666.39 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/pt/documents/overview/lifmior-epar-summary-public_pt.pdf)

română (RO) (690.8 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/ro/documents/overview/lifmior-epar-summary-public_ro.pdf)

slovenčina (SK) (742.1 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/sk/documents/overview/lifmior-epar-summary-public_sk.pdf)

slovenščina (SL) (732.49 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/sl/documents/overview/lifmior-epar-summary-public_sl.pdf)

Suomi (FI) (663.73 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/fi/documents/overview/lifmior-epar-summary-public_fi.pdf)

svenska (SV) (664.65 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/sv/documents/overview/lifmior-epar-summary-public_sv.pdf)

## Product information

Lifmior : EPAR - Product Information

English (EN) (3.25 MB - PDF)

**First published:** 13/03/2017

**Last updated:** 20/02/2020

[View](/en/documents/product-information/lifmior-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-35)

български (BG) (1.91 MB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/bg/documents/product-information/lifmior-epar-product-information_bg.pdf)

español (ES) (2.41 MB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/es/documents/product-information/lifmior-epar-product-information_es.pdf)

čeština (CS) (5.68 MB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/cs/documents/product-information/lifmior-epar-product-information_cs.pdf)

dansk (DA) (2.39 MB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/da/documents/product-information/lifmior-epar-product-information_da.pdf)

Deutsch (DE) (2.62 MB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/de/documents/product-information/lifmior-epar-product-information_de.pdf)

eesti keel (ET) (2.4 MB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/et/documents/product-information/lifmior-epar-product-information_et.pdf)

ελληνικά (EL) (7.56 MB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/el/documents/product-information/lifmior-epar-product-information_el.pdf)

français (FR) (2.48 MB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/fr/documents/product-information/lifmior-epar-product-information_fr.pdf)

hrvatski (HR) (2.39 MB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/hr/documents/product-information/lifmior-epar-product-information_hr.pdf)

íslenska (IS) (2.46 MB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/is/documents/product-information/lifmior-epar-product-information_is.pdf)

italiano (IT) (2.48 MB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/it/documents/product-information/lifmior-epar-product-information_it.pdf)

latviešu valoda (LV) (5.91 MB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/lv/documents/product-information/lifmior-epar-product-information_lv.pdf)

lietuvių kalba (LT) (2.49 MB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/lt/documents/product-information/lifmior-epar-product-information_lt.pdf)

magyar (HU) (5.66 MB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/hu/documents/product-information/lifmior-epar-product-information_hu.pdf)

Malti (MT) (6.04 MB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/mt/documents/product-information/lifmior-epar-product-information_mt.pdf)

Nederlands (NL) (2.59 MB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/nl/documents/product-information/lifmior-epar-product-information_nl.pdf)

norsk (NO) (2.91 MB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/no/documents/product-information/lifmior-epar-product-information_no.pdf)

polski (PL) (6.08 MB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/pl/documents/product-information/lifmior-epar-product-information_pl.pdf)

português (PT) (2.45 MB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/pt/documents/product-information/lifmior-epar-product-information_pt.pdf)

română (RO) (2.51 MB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/ro/documents/product-information/lifmior-epar-product-information_ro.pdf)

slovenčina (SK) (5.59 MB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/sk/documents/product-information/lifmior-epar-product-information_sk.pdf)

slovenščina (SL) (5.44 MB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/sl/documents/product-information/lifmior-epar-product-information_sl.pdf)

Suomi (FI) (2.45 MB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/fi/documents/product-information/lifmior-epar-product-information_fi.pdf)

svenska (SV) (3.58 MB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/sv/documents/product-information/lifmior-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** IG/1082 05/04/2019

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Lifmior : EPAR - All Authorised presentations

English (EN) (610.51 KB - PDF)

**First published:** 13/03/2017

**Last updated:** 20/02/2020

[View](/en/documents/all-authorised-presentations/lifmior-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-71)

български (BG) (691.52 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/bg/documents/all-authorised-presentations/lifmior-epar-all-authorised-presentations_bg.pdf)

español (ES) (609.6 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/es/documents/all-authorised-presentations/lifmior-epar-all-authorised-presentations_es.pdf)

čeština (CS) (645.81 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/cs/documents/all-authorised-presentations/lifmior-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (609.53 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/da/documents/all-authorised-presentations/lifmior-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (610.23 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/de/documents/all-authorised-presentations/lifmior-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (606.97 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/et/documents/all-authorised-presentations/lifmior-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (653.99 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/el/documents/all-authorised-presentations/lifmior-epar-all-authorised-presentations_el.pdf)

français (FR) (607.67 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/fr/documents/all-authorised-presentations/lifmior-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (608.61 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/hr/documents/all-authorised-presentations/lifmior-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (608.15 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/is/documents/all-authorised-presentations/lifmior-epar-all-authorised-presentations_is.pdf)

italiano (IT) (612.85 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/it/documents/all-authorised-presentations/lifmior-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (647.79 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/lv/documents/all-authorised-presentations/lifmior-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (612.9 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/lt/documents/all-authorised-presentations/lifmior-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (659.6 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/hu/documents/all-authorised-presentations/lifmior-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (647.64 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/mt/documents/all-authorised-presentations/lifmior-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (608.44 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/nl/documents/all-authorised-presentations/lifmior-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (608.34 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/no/documents/all-authorised-presentations/lifmior-epar-all-authorised-presentations_no.pdf)

polski (PL) (644.9 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/pl/documents/all-authorised-presentations/lifmior-epar-all-authorised-presentations_pl.pdf)

português (PT) (612.87 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/pt/documents/all-authorised-presentations/lifmior-epar-all-authorised-presentations_pt.pdf)

română (RO) (613.7 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/ro/documents/all-authorised-presentations/lifmior-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (644.63 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/sk/documents/all-authorised-presentations/lifmior-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (639.96 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/sl/documents/all-authorised-presentations/lifmior-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (606.43 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/fi/documents/all-authorised-presentations/lifmior-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (613.33 KB - PDF)

**First published:**

13/03/2017

**Last updated:**

20/02/2020

[View](/sv/documents/all-authorised-presentations/lifmior-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Lifmior Active substance etanercept International non-proprietary name (INN) or common name etanercept Therapeutic area (MeSH)

- Arthritis, Psoriatic
- Spondylitis, Ankylosing
- Psoriasis

Anatomical therapeutic chemical (ATC) code L04AB01

### Pharmacotherapeutic group

Immunosuppressants

### Therapeutic indication

- Rheumatoid arthritis;
- Juvenile idiopathic arthritis
- Psoriatic arthritis;
- Axial spondyloarthritis;
- Plaque psoriasis;
- Paediatric plaque psoriasis.

## Authorisation details

EMA product number EMEA/H/C/004167 Marketing authorisation holder

Pfizer Europe MA EEIG

Boulevard de la Plaine 17

Opinion adopted 15/12/2016 Marketing authorisation issued 13/02/2017 Lapse of marketing authorisation 16/02/2020 Revision 8

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Lifmior : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (902.1 KB - PDF)

**First published:** 18/10/2017

**Last updated:** 20/02/2020

[View](/en/documents/procedural-steps-after/lifmior-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

Lifmior-H-C-4167- WS1362 : EPAR - Assessment Report

Reference Number: EMA/366395/2018

English (EN) (780.44 KB - PDF)

**First published:** 16/07/2018

**Last updated:** 20/02/2020

[View](/en/documents/variation-report/lifmior-h-c-4167-ws1362-epar-assessment-report_en.pdf)

## Initial marketing authorisation documents

Lifmior : EPAR - Public assessment report

Adopted

Reference Number: EMA/114647/2016

English (EN) (957.47 KB - PDF)

**First published:** 13/03/2017

**Last updated:** 20/02/2020

[View](/en/documents/assessment-report/lifmior-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for Lifmior

Adopted

Reference Number: EMA/CHMP/764586/2016

English (EN) (722.23 KB - PDF)

**First published:** 16/12/2016

**Last updated:** 20/02/2020

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-lifmior_en.pdf)

#### News on Lifmior

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 December 2016](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-12-15-december-2016) 16/12/2016

**This page was last updated on** 20/02/2020

## Share this page

[Back to top](#main-content)